Answers are grounded in this paper and cite their sources.
Randomized trial investigates ursodeoxycholic acid dose reduction in primary biliary cholangitis, highlighting therapy maintenance strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zahra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: